ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,856, issued on March 24, was assigned to Blueprint Medicines Corp. (Cambridge, Mass.).

"Inhibitors of protein kinase A" was invented by Neil Bifulco (Cambridge, Mass.), Joseph L. Kim (Cambridge, Mass.), Stefanie Sandra Schalm (Cambridge, Mass.), Kevin J. Wilson (Cambridge, Mass.) and Michael Ross Palmer (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds of Formula (I) and pharmaceutically acceptable salts thereof and solvates of any of the foregoing capable of inhibiting protein kinase A and/or its mutants, pharmaceutical compositions comprising at least one of the compounds, pharmaceutically acceptable ...